Trump drug pricing order to affect innovators, generics spared: IPA

Q: How long will it take to read this news story?

The story "Trump drug pricing order to affect innovators, generics spared: IPA" has 893 words across 35 sentences, which will take approximately 4 - 8 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Trump drug pricing order to affect innovators, generics spared: IPA" was covered 9 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 282 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #28667129</li><li>URL: https://forold.beamstart.com/news/trump-drug-pricing-order-to-17471232505390</li></ul>

Business Standard Logo Business Standard 9h ago

Trump drug pricing order to affect innovators, generics spared: IPA - Business Standard

Quick Summary:

The EO also instructs the administration to communicate price targets to pharma manufacturers, asserting that America, the world’s largest purchaser and funder of prescription drugs, should get the best deal.

Trump had previously said the move would lead to higher drug prices in other countries as part of a broader global price alignment.

IPA, which represents large pharma firms in the country that account for nearly 80 per cent of India's pharma exports by value, felt that the generics industry is unlikely to be impacted as a result of this US move.